JEREMY FRITZSCHE: Open Payments
NPI 1922570837 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,334 in 64 payments from 18 companies in 2025. Trend: 2023 $1,125 · 2024 $1,477 · 2025 $1,334
Food & beverage: $1,334
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 9 | $277 |
| Merck Sharp & Dohme LLC | 9 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $127 |
| Novartis Pharmaceuticals Corporation | 5 | $104 |
| Philips North America LLC | 4 | $92 |
| SCPHARMACEUTICALS INC. | 4 | $81 |
| E.R. Squibb & Sons, L.L.C. | 4 | $79 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
| Kestra Medical Technology Services, Inc. | 3 | $64 |
Products named: Kerendia, VERQUVO, Ambulatory Monitoring & Diagnostics Undivided, LEQVIO, FUROSCIX, CAMZYOS, LifeVest, JARDIANCE.
Industry payments across FL — which companies pay providers there.
